| Title | Oral therapy for riboflavin transporter deficiency - What is the regimen of choice? |
| Publication Type | Journal Article |
| Year of Publication | 2019 |
| Authors | Gorcenco, S, Vaz, FM, Tracewska-Siemiątkowska, A, Tranebjærg, L, Cremers, FPM, Ygland, E, Kicsi, J, Rendtorff, NDahl, Möller, C, Kjellström, U, Andréasson, S, Puschmann, A |
| Journal | Parkinsonism Relat Disord |
| Volume | 61 |
| Pagination | 245-247 |
| Date Published | 2019 04 |
| ISSN | 1873-5126 |
| DOI | 10.1016/j.parkreldis.2018.10.017 |
| Alternate Journal | Parkinsonism Relat. Disord. |
| PubMed ID | 30343981 |
| Grant List | U54 HG006493 / HG / NHGRI NIH HHS / United States |
The Centers for Mendelian Genomics are funded by the National Human Genome Research Institute,
the National Heart, Lung, and Blood Institute, and the National Eye Institute.
the National Heart, Lung, and Blood Institute, and the National Eye Institute.
Broad Institute (UM1 HG008900), Johns Hopkins University School of Medicine/Baylor College of Medicine (UM1 HG006542),
University of Washington (UM1 HG006493), Yale University (UM1 HG006504)
University of Washington (UM1 HG006493), Yale University (UM1 HG006504)